Nader Francois

Director · MRNA, TECX

As of 2026-09-16, Nader Francois has 8 Form 4 transactions on record across 2 companies — 6 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $1.2MIndirect: $0$1.2Mas of 2026-09-16
  • Direct $1.2M
  • Indirect $0
MRNAdirect4,185 sh$609K
TECXdirect20,400 sh$569K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

MRNA · 7 trades
2026-05-06: Award / grant, 4,185 sh ($0)2026-05-06: Award / grant, 6,454 sh ($0)2026-04-30: Option exercise, 12,174 sh ($0)2026-04-30: Option exercise, 12,174 sh2026-04-30: Option exercise, 12,174 sh2025-04-30: Award / grant, 12,174 sh ($0)2025-04-30: Award / grant, 6,378 sh ($0)
TECX · 1 trade
2026-04-01: Award / grant, 20,400 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
8 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-05-06MRNAAward / grant4,1854,185Form 4
2026-05-06MRNAAward / grant6,4546,454Form 4
2026-04-30MRNAOption exercise12,1740Form 4
2026-04-30MRNAOption exercise12,17432,781Form 4
2026-04-30MRNAOption exercise12,17432,781Form 4
2026-04-01TECXAward / grant20,40020,400Form 4
2025-04-30MRNAAward / grant12,17412,174Form 4
2025-04-30MRNAAward / grant6,3786,378Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.